| HOME >> BIOLOGY >> TECHNOLOGY |
Table 26: Fabry Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2008
Table 27: Fabry Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015
Table 28: Fabry Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2001-2008
Table 29: Fabry Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015
Table 30: Fabry Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 31: Pompe Disease Therapeutics Market, Global, Revenue Forecasts ($m), 2005-2008
Table 32: Pompe Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2005-2015
Table 33: Pompe Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2008
Table 34: Pompe Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015
Table 35: Pompe Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2000-2008
Table 36: Pompe Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015
Table 37: Pompe Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2008
Table 38: Pompe Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015
Table 39: Pompe Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2005-2015
Table 40: Pompe Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2000-2008
Table 41: Pompe Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015
Table 42: Mucopolysaccharidosis VI Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 43: Pompe Disease Therapeutics Market, Global, Myozyme Sales, 2008
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |